Showing 5441-5450 of 5909 results for "".
- FDA Does Not Approve Kala Pharmaceuticals’ NDA for Dry Eye Disease Candidatehttps://modernod.com/news/fda-does-not-approve-kala-pharmaceuticals-nda-for-dry-eye-disease-candidate/2476799/Kala Pharmaceuticals announced that it received a complete response letter (CRL) from the FDA regarding the company’s new drug application (NDA) for KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease. The FDA indicated that efficacy data from an additional clinica
- Bausch Health CEO: Big Pharma Will Survive US Drug Regulationshttps://modernod.com/news/bausch-health-ceo-big-pharma-will-survive-us-drug-regulations/2476798/Bausch Health Chariman and CEO Joseph C. Papa told CNBC on Wednesday that he isn’t too concerned about the future of the pharmaceutical industry despite pledges from Congress to lower
- Optronics Introduces Microcast Pro Medical Grade Microscope Video Camera Platformhttps://modernod.com/news/optronics-introduces-microcast-pro-medical-grade-microscope-video-camera-platform/2476796/Optronics announced the introduction of the next generation Microcast, the Microcast 4K PRO 3CMOS 2160p Ultra High Definition, and Microcast HD PRO 3CMOS 1080p high definition microscope video cameras for surgical and other technical microscope imaging applications including pathology, research,
- Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302 in Wet AMDhttps://modernod.com/news/opthea-meets-primary-endpoint-in-phase-2b-study-of-opt-302-in-wet-amd/2476795/Opthea announced positive phase 2b results demonstrating that OPT-302 combination therapy met the primary endpoint of superiority in mean visual acuity gain at 24 weeks compared to Lucentis monotherapy in treatment-naïve patients with wet age-related macular degeneration (AMD). <
- Rare Complication of Eye Surgery Can Kill in a Minutehttps://modernod.com/news/rare-complication-of-eye-surgery-can-kill-in-a-minute/2476790/Ocular venous air embolism, a very rare complication of vitrectomy, is almost always fatal, yet some retina specialists have not heard of it, according to a Medscape report. The complication can kill in less than a minute, said Rob
- Alimera Announces Iluvien Regulatory Approval in Australia for the Treatment of DMEhttps://modernod.com/news/alimera-announces-iluvien-regulatory-approval-in-australia-for-the-treatment-of-dme/2479552/Alimera Sciences announced that the Australian Therapeutic Goods Administration (TGA), the division of the Australian Department of Health that oversees the availability of medical products, has approved Iluvien (190 micrograms intravitreal implant in applicator) for the treatment of diabetic mac
- Perspective: Protocol V Sheds Light on Managing Mild Diabetic Macular Edemahttps://modernod.com/news/perspective-protocol-v-sheds-light-on-managing-mild-diabetic-macular-edema/2479555/When it comes to the treatment of diabetic macular edema (DME), ophthalmologists have overwhelming evidence to guide their decision-making—but only up to a point. DME consists of three clinical subcategories: center-involved DME (CI-DME) with visual acuity (VA) impairment, CI-DME with good
- US Outlines Plans to Allow Importation of Certain Prescription Drugs From Canada, Other Countrieshttps://modernod.com/news/us-outlines-plans-to-allow-importation-of-certain-prescription-drugs-from-canada-other-countries/2479556/The US Department of Health and Human Services (HHS) on Wednesday outlined details of two potential pathways that will allow the importation of certain prescription medicines originally intended for foreign markets. The announcement comes the day after HHS Secretary Alex Azar confirmed that Presi
- BioTime Announces Name Change to Lineage Cell Therapeuticshttps://modernod.com/news/biotime-announces-name-change-to-lineage-cell-therapeutics/2479562/In a move to reflects the company’s commitment to becoming a leading cell therapy company, BioTime announced it is launching a new corporate brand, including a change of its corporate name to Lineage Cell Therapeutics, effective August 12, 2019. In connection with the launch, the com
- CMS Issues Proposed 2020 ASC Payment Rulehttps://modernod.com/news/cms-issues-proposed-2020-asc-payment-rule/2479563/On July 29, the Centers for Medicare and Medicaid Services (CMS) issued its proposed CY 2020 payment rate regulation for hospital outpatient departments (HOPDs) and ambulatory surgery centers (ASCs). The proposed regulation will soon be published in the Federal Register. The Outpatient Ophthalmic